Article Sidebar

PDF
Date Published: 10/12/2025
Abstract Views: 68
Views PDF: 26
DOI: 10.56535/jmpm.v50si4.1625
Issue
Vol. 50 No. si4 (2025): JOURNAL OF MILITARY PHARMACO-MEDICINE - SPECIAL ISSUE 12/2025
Section
Special issue celebrating the 75th anniversary of Military Hospital 103
How to Cite
Pham, N. T., & Do, X. T. (2025). INVESTIGATION OF DEPRESSION DISORDER USING PHQ-9 SCALE AND SOME RELATED FACTORS IN PATIENTS WITH METABOLIC SYNDROME. Journal of Military Pharmaco-medicine, 50(si4), 224-232. https://doi.org/10.56535/jmpm.v50si4.1625

INVESTIGATION OF DEPRESSION DISORDER USING PHQ-9 SCALE AND SOME RELATED FACTORS IN PATIENTS WITH METABOLIC SYNDROME

Ngoc Thao Pham1, , Xuan Tinh Do2
1 Bộ môn - Khoa Chẩn đoán Chức năng, Bệnh viện Quân y 103, Học viện Quân y
2 Bộ môn - Khoa Tâm thần, Bệnh viện Quân y 103, Học viện Quân y

Main Article Content

Abstract

Objectives: To investigate characteristics of depression disorder using PHQ-9 (Patient Health Questionnaire-9) scales and some related factors in patients with metabolic syndrome. Methods: A cross-sectional descriptive study was conducted on 68 patients who were diagnosed with metabolic syndrome according to NCEP-ATP III-2005 (the National Cholesterol Education Program's Adult Treatment Panel III-2005) criteria and were assessed for depressive disorders using the PHQ-9 questionnaire, from July 2024 to April 2025. Results: The rate of patients with depressive disorder with the PHQ-9 score > 4 was 35.3%. Blood glucose level and body fat percentage were positively and significantly correlated with the PHQ-9 score (p < 0.05). The mean PHQ-9 score in female patients was significantly higher than that in male patients (p < 0.05). Conclusion: The rate of depressive disorders in patients with metabolic syndrome was 35.3%. Blood glucose levels, body fat percentage, and sex were factors affecting depressive disorder in patients with metabolic syndrome.

Keywords

Depressive disorders, PHQ-9, Metabolic syndrome

Article Details

References

1. Noubiap JJ, Nansseu JR, Lontchi-Yimagou E, Nkeck JR, Nyaga UF, Ngouo AT, et al. Geographic distribution of metabolic syndrome and its components in the general adult population: A meta-analysis of global data from 28 million individuals. Diabetes Res Clin Pract. 2022; 188:109924.
2. Nebhinani N, Sharma P, Suthar N, Pareek V, Kunwar D, Purohit P, et al. Correlates of metabolic syndrome in patients with depression: A study from north-western India. Diabetes Metab Syndr. 2020; 14(6):1997-2002.
3. Zhang L, Zhou Q, Shao LH, Hu XQ, Wen J, Xia J. Association of metabolic syndrome with depression in US adults: A nationwide cross-sectional study using propensity score-based analysis. Front Public Health. 2023; 11:1081854.
4. Dang AK, Le HT, Nguyen GT, Mamun AA, Do KN, Thi Nguyen LH, et al. Prevalence of metabolic syndrome and its related factors among Vietnamese people: A systematic review and meta-analysis. Diabetes Metab Syndr. 2022; 16(4):102477.
5. Vu LG, Le LK, Dam AVT, Nguyen SH, Vu TTM, Trinh TTH, et al. Factor structures of patient health questionnaire-9 instruments in exploring depressive symptoms of suburban population. Front Psychiatry. 2022; 13:838747.
6. Tran NN, Nguyen VQ, Vo HL, Hoang TP, Bui VS, Nguyen VT. Depression among patients with type 2 diabetes mellitus: Evidence from the Northeast region of Vietnam. Diabetes Metab Syndr. 2021; 15(6):102293.
7. Zhou LN, Ma XC, Wang W. Incidence and risk factors of depression in patients with metabolic syndrome. World J Psychiatry. 2024; 14(2):245-254.
8. Meng X, Han L, Fu J, Hu C, Lu Y. Associations between metabolic syndrome and depression, and the mediating role of inflammation: Based on the NHANES database. J Affect Disord. 2025; 375:214-221.
9. Liu H, Dong H, Zhou Y, Jin M, Hao H, Yuan Y, Jia H. The association between Metabolic Score for Visceral Fat and depression in overweight or obese individuals: Evidence from NHANES. Front Endocrinol (Lausanne). 2024; 15:1482003.
10. Pyykkönen AJ, Räikkönen K, Tuomi T, Eriksson JG, Groop L, Isomaa B. Association between depressive symptoms and metabolic syndrome is not explained by antidepressant medication: Results from the PPP-Botnia Study. Ann Med. 2012; 44(3):279-288.